AUSNATE

MRP

MRP 230.05/Unit

Description

Doses

• As directed by the physician.

Indication

• Parenteral artesunate should be used for the treatment ofsevere falciparum malaria only where there is evidence that the antimalarial efficacy of quinine is declining. The powder for injection is difficult to dissolve and care should be taken to ensure that it is completely dissolved before parenteraladministration.